India’s pharma regulatory failures point to a deeper structural flawAuthorPosted bypeoplic.comPublishedOctober 16, 20256:52 pmX (Twitter)FacebookLinkedInShare this postShare this postClose sharing boxIndia’s pharma regulatory failures point to a deeper structural flawX (Twitter)FacebookLinkedInPosted by peoplic.com on October 16, 2025. These are not independent, random occurrences. They are all pointers to a larger, more fundamental issue Post Views: 1